Sort
30,917 grants matching “tumor microenvironment”
Metabolic alterations in advanced Breast Cancer and response to systemic therapy.
$342,269David Mark Hockenbery · Fred Hutchinson Cancer Research Center · P50 · FY2013 · CA
Role of Bone in Primary and Metastatic Cancer
$342,268Roberta Faccio · Washington University · R01 · FY2024 · CA
Core D: Digital Pathology and CyTOF
$342,221Robert A Anders · Johns Hopkins University · P01 · FY2023 · CA
Environmentally-adaptive nanoparticles with focal irradiation for cancer therapy
$342,216Yoon Yeo · Purdue University · R01 · FY2015 · EB
An Inducible Swine Hepatocellular Carcinoma Platform for Enhanced Therapeutic Development
$342,154Derek Matthew Korpela · Recombinetics, Inc. · R43 · FY2023 · CA
Cellular plasticity and equilibrium in GBM progression
$342,103Atique U. Ahmed · Northwestern University At Chicago · R01 · FY2019 · NS
Mechanisms of Pancreatic Inflammation, Tissue Repair and Carcinogenesis
$342,097Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Biomaterial Mimicry of Dynamic Matrix Stiffening During Tumor Progression
$342,088Adam J Engler · University Of California, San Diego · R01 · FY2019 · CA
Rb & E2Fs Regulating Stromal/Epithelial Interactions during Breast Carcinogenesis
$342,080Gustavo Walter Leone · Ohio State University · P01 · FY2008 · CA
Development of tools for analyzing cell-cell communication using spatial transcriptomic data
$342,064Qing Nie · University Of California-Irvine · R01 · FY2025 · GM
Provectors for treatment of ovarian cancer
$342,044Gang Bao · Rice University · R01 · FY2019 · CA
Heparanase in Tumor Progression, Metastasis and Chemoresistance
$342,011Ralph D Sanderson · University Of Alabama At Birmingham · R01 · FY2020 · CA
Heparanase in Tumor Progression, Metastasis and Chemoresistance
$342,011Ralph D Sanderson · University Of Alabama At Birmingham · R01 · FY2021 · CA
Novel Nanotechnologies and Molecular Imaging Approaches for Cancer Immunotherapy
$342,009Caius Gabriel Radu · California Institute Of Technology · U54 · FY2013 · CA
Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells
$342,009Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2020 · CA
Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells
$342,008Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2021 · CA
Role of p53 Missense Mutations on Tumorigenesis in Vivo
$342,000Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites
$342,000Sandra W Ryeom · University Of Pennsylvania · R01 · FY2015 · CA
Alternative NF-kB in Bone Microenvironment
$342,000Deborah V Novack · Washington University · R01 · FY2015 · AR
Role of p53 Missense Mutations on Tumorigenesis in Vivo
$342,000Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites
$342,000Sandra W Ryeom · University Of Pennsylvania · R01 · FY2016 · CA
Role of p53 Missense Mutations on Tumorigenesis in Vivo
$342,000Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA
Alternative NF-kB in Bone Microenvironment
$342,000Deborah V Novack · Washington University · R01 · FY2011 · AR
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites
$342,000Sandra W Ryeom · University Of Pennsylvania · R01 · FY2017 · CA
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites
$342,000Sandra W Ryeom · University Of Pennsylvania · R01 · FY2018 · CA